UGT1A Antibodies

Santa Cruz Biotechnology delivers a wide array of UGT1A monoclonal antibodies for research focused on UDP-glucuronosyltransferase 1A (UGT1A) enzymes. UGT1A Antibodies are optimized for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UGT1A enzymes play essential roles in metabolizing various endogenous and exogenous compounds, including drugs, hormones, and bilirubin. The metabolic activity of UGT1A enzymes drives critical detoxification processes and regulates important physiological functions, making them a key focus in pharmacology and toxicology research. Understanding UGT1A function has significant implications for human health, as altered enzyme activity can contribute to various pathological conditions. Investigating UGT1A enzymes helps advance knowledge about drug metabolism, hormone regulation, and cellular detoxification pathways. Research utilizing UGT1A monoclonal antibodies enables detailed examination of enzyme localization, expression patterns, and protein interactions. Exploring UGT1A biology provides valuable insights for developing new therapeutic approaches and improving drug efficacy. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of UGT1A enzymes and their impact on human health.